BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Clinical trial NCT00828009 · COMPLETED
Trial details
- NCT number
- NCT00828009
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-17
- Primary completion
- 2018-08-20
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.